跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 901 条关于
“adalimumab-aaty”
全部
901
临床试验
677
药物
88
机构
2
资讯
134
11个月前
FDA Approves Expanded Pediatric Indications for YUFLYMA Biosimilar, Extending Treatment Options for Adolescent Hidradenitis Suppurativa and Pediatric Uveitis
去年
Four New Humira Biosimilars Launch in US Market with Steep Discounts up to 85%
去年
Regeneron Appeals Eylea Biosimilar Ruling; Prime Therapeutics Adds Humira Biosimilars; Denosumab Biosimilar Advances
去年
Secukinumab and Adalimumab Show Distinct Benefits in Psoriatic Arthritis Treatment
4年前
Celltrion Pursues Adalimumab Interchangeability as Formycon Reports Positive Ustekinumab Biosimilar Data
去年
Adalimumab Biosimilar Shows Similar Patient-Reported Outcomes to Humira in Rheumatoid Arthritis Trial
去年
Adalimumab Biosimilar SB5 Shows Similar Persistence in New and Switched Patients with Inflammatory Diseases
去年
Algeria Approves Sino Biopharmaceutical's Adalimumab Biosimilar for Autoimmune Disease Treatment
9个月前
Biocon Biologics Secures Full Global Manufacturing Rights for Adalimumab Biosimilar Hulio
去年
Ten Adalimumab Biosimilars Now Available in US Market Following Latest FDA Approval
第 1 页,共 14 页
上一页
下一页